Form 4: Accendra CFO Sells Shares for Tax Obligations
Insider Transaction Report
Accendra Health's EVP & CFO, Jonathan A. Leon, disposed of 11,286 common shares to cover tax withholding obligations related to vested restricted stock.
Summary
- Jonathan A. Leon, Executive Vice President and Chief Financial Officer of Accendra Health Inc. (ACH), reported a transaction involving the company's common stock.
- On March 20, 2026, Mr. Leon disposed of 11,286 shares of common stock.
- This disposition was made to satisfy tax withholding obligations in connection with the vesting of restricted stock granted to Mr. Leon.
- The shares were valued at $2.03 per share for the purpose of this tax withholding transaction.
- Following this reported transaction, Mr. Leon beneficially owns 292,303 shares of Accendra Health Inc. common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a mandatory tax withholding transaction rather than a discretionary sale or purchase, which is a common occurrence for executives receiving equity compensation.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those related to tax withholdings on vested equity, are common and generally not indicative of a change in management's long-term view of the company. This is a routine compliance filing.
Stakeholder Impact
- Minimal direct impact on shareholders as this is a routine tax-related transaction and not a discretionary sale indicating a change in management's confidence.
Key Dates
| Date | Description |
|---|---|
| 03/20/2026 | Transaction Date: Shares surrendered to the Issuer to satisfy tax withholding obligations. |
| 03/24/2026 | Signature Date of Reporting Person for the filing. |
Recommendation
holdThis Form 4 filing details a routine tax-related disposition of shares by a key executive following the vesting of restricted stock. Such transactions are common and generally do not reflect a change in the executive's confidence in the company's future prospects. Therefore, it provides no new information that would warrant a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this filing.
Keywords
Accendra Health, ACH, Form 4, Insider Transaction, Jonathan A. Leon, CFO, Stock Sale, Tax Withholding, Restricted Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.